ATNF U.S.: Nasdaq

    180 Life Sciences Corp.

    After Hours
    Last Updated: Oct 22, 2021 7:15 p.m. EDT Delayed quote

    $ 5.69

    0.28 5.18%
    After Hours Volume: 343
    Close Chg Chg %
    $5.41 -0.21 -3.74%
    Advanced Charting
    Volume: 321.06K 65 Day Avg: 717.35K
    45% vs Avg
    5.34 Day Range 5.62
    1.90 52 Week Range 13.05

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    ATNF Overview


    5 Day
    • -3.57%
    1 Month
    • -2.35%
    3 Month
    • -37.02%
    • 98.17%
    1 Year
    • -51.00%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 1 Full Ratings

    Why 180 Life Sciences Stock Is Falling Today

    on Motley Fool

    Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Tuesday Morning

    on InvestorPlace.com

    7 Reddit Penny Stocks to Buy for a Biotech Boom

    on InvestorPlace.com

    5 Reddit Penny Stocks Seeing the Most Chatter Friday

    on InvestorPlace.com

    DISCB and 6 Other Reddit Stocks Waiting for a Short Squeeze

    on InvestorPlace.com

    ATNF Stock: Why 180 Life Sciences Is Soaring Higher Today

    on InvestorPlace.com

    10 Reddit Penny Stocks Seeing the Most Chatter Today

    on InvestorPlace.com

    5 Reddit Stocks Seeing More Chatter Than Usual on r/WSB Today

    on InvestorPlace.com

    7 Reddit Penny Stocks Seeing the Most Chatter Today

    on InvestorPlace.com

    180 Life Sciences Corp.

    180 Life Sciences Corp. develops pharmaceuticals for chronic pain and inflammatory diseases. It operates as a clinical-stage biotechnology company focused on the development of novel drugs that fulfil unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded on September 7, 2016 and is headquartered in Palo Alto, CA.